1. Market Research
  2. > Zenotech Laboratories Limited - Product Pipeline Review - 2013

Zenotech Laboratories Limited - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 32 pages

Zenotech Laboratories Limited - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Zenotech Laboratories Limited - Product Pipeline Review - 2013” provides data on the Zenotech Laboratories Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Zenotech Laboratories Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Zenotech Laboratories Limited and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Zenotech Laboratories Limited - Brief Zenotech Laboratories Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Zenotech Laboratories Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Zenotech Laboratories Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Zenotech Laboratories Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Zenotech Laboratories Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Zenotech Laboratories Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Zenotech Laboratories Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Zenotech Laboratories Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Zenotech Laboratories Limited and identify potential opportunities in those areas.

Table Of Contents

Zenotech Laboratories Limited - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Zenotech Laboratories Limited Snapshot 5
Zenotech Laboratories Limited Overview 5
Key Information 5
Key Facts 5
Zenotech Laboratories Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Zenotech Laboratories Limited - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Zenotech Laboratories Limited - Pipeline Products Glance 10
Zenotech Laboratories Limited - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Zenotech Laboratories Limited - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Zenotech Laboratories Limited - Unknown Stage Pipeline Products 12
Unknown Products/Combination Treatment Modalities 12
Zenotech Laboratories Limited - Drug Profiles 13
etanercept biosimilar 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
rituximab biosimilar 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
interferon beta-1b Biosimilar 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Pegfilgrastim biosimilar 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
bevacizumab Biosimilar 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
darbepoetin Biosimilar 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
interferon beta 1a Biosimilar 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
ranibizumab biosimilar 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
trastuzumab biosimilar 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Zenotech Laboratories Limited - Pipeline Analysis 22
Zenotech Laboratories Limited - Pipeline Products by Therapeutic Class 22
Zenotech Laboratories Limited - Pipeline Products by Target 23
Zenotech Laboratories Limited - Pipeline Products by Route of Administration 25
Zenotech Laboratories Limited - Pipeline Products by Molecule Type 26
Zenotech Laboratories Limited - Pipeline Products by Mechanism of Action 27
Zenotech Laboratories Limited - Locations And Subsidiaries 29
Head Office 29
Other Locations and Subsidiaries 29
Zenotech Laboratories Limited - Key Manufacturing Facilities 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32



List of Tables

Zenotech Laboratories Limited, Key Information 5
Zenotech Laboratories Limited, Key Facts 5
Zenotech Laboratories Limited - Pipeline by Indication, 2013 7
Zenotech Laboratories Limited - Pipeline by Stage of Development, 2013 8
Zenotech Laboratories Limited - Monotherapy Products in Pipeline, 2013 9
Zenotech Laboratories Limited - Phase III, 2013 10
Zenotech Laboratories Limited - Preclinical, 2013 11
Zenotech Laboratories Limited - Unknown, 2013 12
Zenotech Laboratories Limited - Pipeline by Therapeutic Class, 2013 22
Zenotech Laboratories Limited - Pipeline by Target, 2013 24
Zenotech Laboratories Limited - Pipeline by Route of Administration, 2013 25
Zenotech Laboratories Limited - Pipeline by Molecule Type, 2013 26
Zenotech Laboratories Limited - Pipeline Products by Mechanism of Action, 2013 28
Zenotech Laboratories Limited, Other Locations 29
Zenotech Laboratories Limited, Subsidiaries 29
Zenotech Laboratories Limited, Key Manufacturing Facilities 30



List of Figures

Zenotech Laboratories Limited - Pipeline by Top 10 Indication, 2013 7
Zenotech Laboratories Limited - Pipeline by Stage of Development, 2013 8
Zenotech Laboratories Limited - Monotherapy Products in Pipeline, 2013 9
Zenotech Laboratories Limited - Pipeline by Top 10 Therapeutic Class, 2013 22
Zenotech Laboratories Limited - Pipeline by Top 10 Target, 2013 23
Zenotech Laboratories Limited - Pipeline by Top 10 Route of Administration, 2013 25
Zenotech Laboratories Limited - Pipeline by Top 10 Molecule Type, 2013 26
Zenotech Laboratories Limited - Pipeline Products by Top 10 Mechanism of Action, 2013 27



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.